Structural characterization of thioether-bridged bacteriocins

Bacteriocins are a group of ribosomally synthesized antimicrobial peptides produced by bacteria, some of which are extensively post-translationally modified. Some bacteriocins, namely the lantibiotics and sactibiotics, contain one or more thioether bridges. However, these modifications complicate the structural elucidation of these bacteriocins using conventional techniques. This review will discuss the techniques and strategies that have been applied to determine the primary structures of lantibiotics and sactibiotics. A major challenge is to identify the topology of thioether bridges in these peptides (i.e., which amino-acid residues are involved in which bridges). Edman degradation, NMR spectroscopy and tandem MS have all been commonly applied to characterize these bacteriocins, but can be incompatible with the post-translational modifications present. Chemical modifications to the modified residues, such as desulfurization and reduction, make the treated bacteriocins more compatible to analysis by these standard peptide analytical techniques. Despite their differences in structure, similar strategies have proved useful to study the structures of both lantibiotics and sactibiotics.

[1]  A. Yousef,et al.  N‐terminal acetylation in paenibacillin, a novel lantibiotic , 2008, FEBS letters.

[2]  J. Vederas,et al.  Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile , 2010, Proceedings of the National Academy of Sciences.

[3]  Weixin Tang,et al.  The Sequence of the Enterococcal Cytolysin Imparts Unusual Lanthionine Stereochemistry , 2013, Nature chemical biology.

[4]  W. A. van der Donk,et al.  Biosynthesis and mode of action of lantibiotics. , 2005, Chemical reviews.

[5]  J. Vederas,et al.  The 3D structure of thuricin CD, a two-component bacteriocin with cysteine sulfur to α-carbon cross-links. , 2011, Journal of the American Chemical Society.

[6]  J. Vederas,et al.  Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. , 2004, Biochemistry.

[7]  G. Jung,et al.  The tetracyclic lantibiotic actagardine. 1H-NMR and 13C-NMR assignments and revised primary structure. , 1995, European journal of biochemistry.

[8]  J. Vederas,et al.  Structure of subtilosin A, an antimicrobial peptide from Bacillus subtilis with unusual posttranslational modifications linking cysteine sulfurs to alpha-carbons of phenylalanine and threonine. , 2003, Journal of the American Chemical Society.

[9]  J. Vederas,et al.  Structural characterization of the highly cyclized lantibiotic paenicidin A via a partial desulfurization/reduction strategy. , 2012, Journal of the American Chemical Society.

[10]  K. Entian,et al.  Entianin, a Novel Subtilin-Like Lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with High Antimicrobial Activity , 2011, Applied and Environmental Microbiology.

[11]  Pavel A Pevzner,et al.  Imaging mass spectrometry of intraspecies metabolic exchange revealed the cannibalistic factors of Bacillus subtilis , 2010, Proceedings of the National Academy of Sciences.

[12]  A. Mattick,et al.  A Powerful Inhibitory Substance Produced by Group N Streptococci , 1944, Nature.

[13]  J. Vederas,et al.  Synthesis of the lantibiotic lactocin S using peptide cyclizations on solid phase. , 2010, Journal of the American Chemical Society.

[14]  B. Eisermann,et al.  Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. , 1994, Analytical biochemistry.

[15]  H. Sahl,et al.  Lantibiotics: mode of action, biosynthesis and bioengineering. , 2009, Current pharmaceutical biotechnology.

[16]  E. Nebelin,et al.  [Subtilin, VI: the structure of subtilin (author's transl)]. , 1973, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[17]  K. Mineev,et al.  Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. , 2010, Biochemistry.

[18]  P. G. Arnison,et al.  Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. , 2013, Natural product reports.

[19]  E. Gross,et al.  The structure of nisin. , 1971, Journal of the American Chemical Society.

[20]  W. A. van der Donk,et al.  Discovery, biosynthesis, and engineering of lantipeptides. , 2012, Annual review of biochemistry.

[21]  S. Stevanović,et al.  In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. , 1994, The Journal of biological chemistry.

[22]  Neha Garg,et al.  Lantibiotics from Geobacillus thermodenitrificans , 2012, Proceedings of the National Academy of Sciences.

[23]  R. P. Ross,et al.  Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters , 2011, PloS one.

[24]  J. Vederas,et al.  The 3D solution structure of thurincin H, a bacteriocin with four sulfur to α-carbon crosslinks. , 2011, Angewandte Chemie.

[25]  Kunling Teng,et al.  Dissection of the bridging pattern of bovicin HJ50, a lantibiotic containing a characteristic disulfide bridge. , 2011, Microbiological research.

[26]  J. Vederas,et al.  Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147. , 2011, Journal of the American Chemical Society.

[27]  A. Mattick,et al.  Further observations on an inhibitory substance (nisin) from lactic streptococci. , 1947, Lancet.

[28]  J. Vederas,et al.  Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives. , 2004, Biochemistry.

[29]  N. Kelleher,et al.  Lacticin 481: In Vitro Reconstitution of Lantibiotic Synthetase Activity , 2004, Science.

[30]  A. Yousef,et al.  Isolation and Identification of a Paenibacillus polymyxa Strain That Coproduces a Novel Lantibiotic and Polymyxin , 2006, Applied and Environmental Microbiology.

[31]  M. Marahiel,et al.  The radical SAM enzyme AlbA catalyzes thioether bond formation in subtilosin A. , 2012, Nature chemical biology.

[32]  K. Entian,et al.  Gallidermin: a new lanthionine-containing polypeptide antibiotic. , 1988, European journal of biochemistry.

[33]  K. Entian,et al.  Pep5: Structure Elucidation of a Large Lantibiotic , 1989 .

[34]  K. Wüthrich.  NMR of proteins and nucleic acids , 1988 .

[35]  F. Vasile,et al.  Structure revision of the lantibiotic 97518. , 2009, Journal of natural products.

[36]  R. Süssmuth,et al.  Curvopeptin: A New Lanthionine‐Containing Class III Lantibiotic and its Co‐substrate Promiscuous Synthetase , 2012, Chembiochem : a European journal of chemical biology.

[37]  J. Vederas,et al.  Structure and genetics of circular bacteriocins. , 2011, Trends in microbiology.

[38]  G. LaPointe,et al.  Purification and structure of mutacin B‐Ny266: a new lantibiotic produced by Streptococcus mutans , 1997, FEBS letters.

[39]  G. Jung,et al.  Elucidation of the Structure of Epidermin, a Ribosomally Synthesized, Tetracyclic Heterodetic Polypeptide Antibiotic , 1985 .